Neurotoxicity Syndromes - Pathology
Research News and Information

Sunday, November 22, 2009

DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of beta-tubulin subtypes in the CNS of hens contributes to OPIDN.

3 Aug 2009 Organophosphorus ester-induced delayed neurotoxicity (OPIDN) is a neurodegenerative disorder characterized by ataxia progressing to paralysis with a concomitant central and peripheral distal axonapathy. Diisopropylphosphorofluoridate (DFP) produces ... Read more...

An extract of Hydrilla verticillata and associated epiphytes induces avian vacuolar myelinopathy in laboratory mallards.

30 Jul 2009 Avian vacuolar myelinopathy (AVM) is a neurological disease affecting bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), waterfowl, and other birds in the southeastern United States. The cause of the disease is unknown, but ... Read more...

Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.

27 Jul 2009 Environmental exposure to neurotoxic metals through various sources including exposure to welding fumes has been linked to an increased incidence of Parkinson's disease (PD). Welding fumes contain many different metals including vanadium typically ... Read more...

Latest indexed articles for 'Neurotoxicity Syndromes - Pathology'

These are the very latest articles for this heading:

• DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of beta-tubulin subtypes in the CNS of hens contributes to OPIDN. 3 Aug 2009
• An extract of Hydrilla verticillata and associated epiphytes induces avian vacuolar myelinopathy in laboratory mallards. 30 Jul 2009
• Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease. 27 Jul 2009
• Nanoimages show disruption of tubulin polymerization by chlorpyrifos oxon: implications for neurotoxicity. 20 Jul 2009
• Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. 12 Jul 2009
• Acute toxic encephalopathy due to the ingestion of Rhus extract. 28 Jun 2009
• Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. 4 Jun 2009
• Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. 18 May 2009
• Spinal procaine is less neurotoxic than mepivacaine, prilocaine and bupivacaine in rats. 29 Apr 2009
• Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity. 26 Apr 2009
• Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. 15 Apr 2009
• Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. 7 Apr 2009
• Erythropoietin in the treatment of encephalopathy associated with carbon monoxide poisoning. 26 Mar 2009
• Methamphetamine toxicity and messengers of death. 23 Mar 2009
• Cytoplasmic prion protein induces forebrain neurotoxicity. 8 Mar 2009
• Selective aspiration or neurotoxic lesions of orbital frontal areas 11 and 13 spared monkeys' performance on the object discrimination reversal task. 2 Mar 2009
• Mothball mayhem: relapsing toxic leukoencephalopathy due to p-dichlorobenzene neurotoxicity. Mar 2009
• Erythropoietin protects primary cultures of rat cortical neurons from hypoxia-induced toxicity through attenuating both glutamate release and NMDA receptor evoked neurotoxicity pathway. 27 Feb 2009
• Electrophysiological correlates of intermediate syndrome following acute organophosphate poisoning. 27 Feb 2009
• Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys. 22 Feb 2009

See a longer list of these articles.

Technical information about 'Neurotoxicity Syndromes'

Definition: Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.

Descriptor UI: D020258

Alternative terms: Neurotoxicity Syndromes; Neurotoxicity Syndrome; Syndrome, Neurotoxicity; Syndromes, Neurotoxicity; Neurotoxin Disorders; Neurotoxin Disorder; Neurotoxic Disorders; Neurotoxic Disorder; Neurotoxin Diseases; Neurotoxin Disease; Poisoning, Nervous System; Nervous System Poisonings; Poisonings, Nervous System; Nervous System Poisoning; Encephalopathy, Toxic; Encephalopathies, Toxic; Toxic Encephalopathies; Toxic Encephalopathy; Toxic Encephalitis; Encephalitides, Toxic; Encephalitis, Toxic; Toxic Encephalitides;

Allowable Qualifiers: blood; cerebrospinal fluid; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.720; C21.613.705;

History Note: 2000